Analyzing the options chain and the chart patterns of ACVH Achieve Life Sciences prior to the earnings report this week, I would consider purchasing the 5usd strike price Calls with an expiration date of 2024-6-21, for a premium of approximately $0.65. If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
ACHV had good earnings in mid-March and has been in an ascending triangle since that time. The uptrend had a correction April 17th to 20th to which buyers responded with spiking buying volume. Current volume is 3x relative to the usual and customary historical volume averages. I will take a long trade on this when price descends to the support trendline...
ACHC previously ran up in a high tight flag pattern in my previous idea. It has been slowly ascending in a narrowing channel. ( ascending wedge) There has been a little push in volume on the indicator as price has approached the upper boundaries of the channel. The average directional index has decreased into the " chop zone" where consolidation and lack...
ACHV on the 4H seems to be demonstrating a "High Bull Flag Pattern" after a big uptrend to start the year. Earnings on Thursday 3/16 were quite favorable.On the relative volume indicator Friday, May 17th showed a paradoxical huge selling volume spike to finish out this week. ( I mislabelled this as upcoming on the chart) Paradoxically, the last earnings...
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine...
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic...
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic...
ACHV ACHIEVE LIFE SCIENCE INC NASDAQ trendline. If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
On 8/7/2020 Brokerage LADENBURG THALM/SH SH Reiterated ACHV Rating to BUY and set the target price to $100.00, now the cost of one share is 9.84usd. You can find the asset on trading212, the most downloaded trading app in the U.K. With a market cap of $15.45 million and a worldwide working product, it`s hard to say ACHV can go lower than that. The only concern is...
On July 31th : Achieve Life Sciences receives U.S. patent for its novel analogs of cytisinicline for use in prevention or treatment of CNS and addictive disorders. Aimed at regaining compliance with Nasdaq's $1 minimum bid price listing requirement, Achieve Life Sciences has executed a 1:20 reverse split of its common stock. Achieve Life Sciences is scheduled...
Hi, today we are going to talk about Achieve Life Sciences and its current landscape. Achieve Life Sciences has been surrounded by increasing speculation over its shares after a couple of days ago had unveiled an update on the cytisinicline (a drug to aid smoking cessation ) clinical development program, as the FDA had agreed with the overall Phase 3 study...